Table 5 Comparing those CHB patients with excessive orthostatic symptoms (OGS > 1.8) and fatigue (FIS ≥ 25) with those without

n

39

39

15

40

Female(%)

21 (26.9)

5 (6.4)

12 (20)

10 (40)

Age (years)

36.5 ± 10.2

37.1 ± 11.2

35.2 ± 8.5

33.310.6

BMI (kg/m2)

24.3 ± 4.1

25.8 ± 5.5

23.5 ± 4.2

23.8 ± 3.9

Albumin(g/l)

45.5 ± 4.6

44.9 ± 3.8

45.4 ± 2.9

44.2 ± 3.2

ALT(U/L)

54.9 ± 48.7

37.9 ± 19.9

30.2 ± 16.1

66.2 ± 57.1

AST(U/L)

40.3 ± 26.2

31.2 ± 13.7

27.1 ± 8.6

42.9 ± 39.8

BiL (umol/L)

16.5 ± 10.8

15.6 ± 5.2

17.4 ± 9.2

14.5 ± 9.8

Log₁₀HBVDNA(copies/dl)

9.7 ± 0.5

4.5 ± 0.1

2.4 ± 0.4

5.2 ± 0.1

Inflammation Grade(G1/G2/G3/G4)

28/17/9/1

13/7/1/2

15/8/0/0

20/19/8/5

Fibrosis stage(F0/F1/F2/F3/F4)

8/28/10/4/5

3/9/5/2/4

3/9/10/1/0

5/18/6/1/2